Dr. Judith Ford received a Ph.D. in Physics in 1978 from Cambridge University UK, and subsequently obtained her Boards in Internal Medicine (MRCP) in 1985 and in Radiation Oncology (FRCR) in 1993. Her previous appointments include Clinical Research Scientist in the Department of Clinical Oncology and Radiotherapeutics in Cambridge, and Radiation Oncologist for Wellington Hospital in New Zealand.
Dr. Ford's main interests are in primary and secondary brain tumors, stereotactic radiosurgery, breast cancer and metastatic cancer. Since joining the faculty at UCLA in 1996, Dr. Ford has developed a prospective clinical research program in primary and secondary brain tumors. This includes an NCI sponsored phase I clinical trial of the radiation sensitizer Motexafin Gadolinium (previously known as Gadolinium Texaphyrin) in Glioblastoma Multiforme, and the National Brain Tumor Foundation funded research in quality of life for patients with brain metastases.
Dr. Ford is currently putting her UK and New Zealand experience in Internal Medicine, Medical Oncology and End-of-Life Care to use in developing an Acute Inpatient Palliative Care Unit at Santa Monica UCLA Medical Center together with Palliative Care Consult services for both UCLA hospitals.
Does this profile need updating? Contact Us